M Elkhashab

Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

Kosh Agarwal, Sang Hoon Ahn, M Elkhashab et al. · Journal of Viral Hepatitis · 2018 · 93 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B

Patrick Marcellin, Sang Hoon Ahn, Wan‐Long Chuang et al. · Alimentary Pharmacology & Therapeutics · 2016 · 44 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection genotype 1–6 and chronic kidney disease: an integrated analysis

Stanislas Pol, Paul J. Pockros, David Pugatch et al. · Journal of Hepatology · 2017 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +12

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

Henry Lik‐Yuen Chan, Sang Hoon Ahn, Wan‐Long Chuang et al. · Journal of Hepatology · 2015 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +15

Continued therapy with ABI-H0731+NRTI results in sequential reduction/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg positive patients

Sulkowski, Kosh Agarwal, SK Fung et al. · Hepatology · 2019 · 13 citations

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10